Otros idiomas Better Therapeutics, Inc.

Acciones

BTTX

US08773T1043

Mercado cerrado - OTC Markets Otros sitios de cotización 21:33:21 28/06/2024			Varia. Cinco días.	Varia. 1 de enero.
0,0125 ^USD	+13,64 %		+86,57 %	-93,59 %

22/05	Click Therapeutics, Inc. adquirió Assets of Better Therapeutics, Inc. (OTCPK:BTTX).	CI
21/03	Better Therapeutics, Inc. Recibe Notificación de Incumplimiento de Hercules Capital, Inc.	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

Click Therapeutics Accelerates Expansion into Obesity and Cardiometabolic Disease With Acquisition of the Assets of Better Therapeutics, Inc.	23/05
Click Therapeutics, Inc. acquired Assets of Better Therapeutics, Inc..	22/05
Better Therapeutics, Inc. Receives Notice of Default from Hercules Capital, Inc	21/03
Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from S&P TMI Index	20/03
Better Therapeutics, Inc.(NasdaqCM:BTTX) dropped from NASDAQ Composite Index	15/03
Sector Update: Health Care Stocks Lower Thursday Afternoon	14/03
Better Therapeutics to Terminate Employees, Explore Strategic Alternatives; Shares Drop Sharply	14/03
Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq	14/03
Better Therapeutics : Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq - Form 8-K	14/03
Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers	05/03
Better Therapeutics Announces Acceptance of Late Breaking Abstract for Its AspyreRx Pivotal Trial 180 Day Outcomes and Participation at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)	04/03
Transcript: Better Therapeutics CEO Interview with RedChip - Form 8-K	04/03
Better Therapeutics' Platform Targeting Advanced Liver Disease Receives FDA Breakthrough Device Designation	20/02
Better Therapeutics Gets Breakthrough Device Designation For Cognitive Behavioral Therapy Platform	20/02
Better Therapeutics Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease	20/02
Better Therapeutics, Inc. Receives FDA Breakthrough Device Designation for Digital Therapeutic Platform Targeting Advanced Liver Disease	20/02
Better Therapeutics Signs Rebate Agreement with One of the Largest Pharmacy Benefit Managers in the US for its AspyreRx Diabetes Treatment	06/02
Better Therapeutics, Inc. announced that it has received $0.25 million in funding	23/01
Better Therapeutics Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx is More Effective and Less Costly than Standard of Care Alone	17/01
Better Therapeutics Inc. Announces Publication of Cost-Effectiveness Analysis Demonstrating AspyreRx Is More Effective and Less Costly Than Standard of Care Alone	17/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas Better Therapeutics, Inc.

Acciones

BTTX

US08773T1043

Otros idiomas

Filtros